Signature Wealth Management Partners, LLC Acelrx Pharmaceuticals Inc Transaction History

Signature Wealth Management Partners, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Jul 29, 2021	SELL	$1.03 - $1.7 $56,650 - $93,500	-55,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$1.25 - $2.77 $68,750 - $152,350	55,000 New	55,000 $94,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Signature Wealth Management Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Signature Wealth Management Partners, LLC with notifications on news.